Tag: GLTx

11
Mar

GLTx EndoC-βH5®

Revolutionize Your Glucolipotoxicity-Mediated T2D Research Open new avenue using a unique clinically relevant cell model. GLTx EndoC-βH5® is a new human pancreatic beta cell line that has been specifically designed to recapitulate pathological glucolipotoxicity-induced dysfunction as observed in Type 2 Diabetes patients. GLTx EndoC-βH5® cell line offers you: